Navigation Links
Patient Safety Technologies Reports Third Quarter 2008 Results
Date:11/24/2008

35 - Prepaid expenses 309 105 Total current assets 1,707 582 Restricted certificate of deposit 87 87 Notes receivable 154 154 Property and equipment, net 721 663 Assets held for sale, net 90 406 Goodwill 1,832 1,832 Patents, net 3,520 3,764 Long-term investment 667 667 Other assets 29 19 Total assets $8,807 $8,174 Liabilities and Stockholders' (Deficit) Equity Current liabilities Accounts payable $603 $709 Current portion of long term debt 2,946 1,172 Accrued liabilities 3,303 521 Total current liabilities 6,852 2,402 Long-term debt, less current portion - 2,531 Deferred tax liabilities 1,403 1,499 Total liabilities 8,255 6,431 Stockholders' equity: Convertible preferred stock, $1.00 par value, cumulative 7% dividend: 1,000 shares authorized; 11 issued and outstanding at September 30, 2008 and December 31, 2007 (Liquidation preference of $1.2 million at September 30, 2008 and December 31, 2007 11 11 Common stock, $0.33 par value: 25,000
'/>"/>
SOURCE Patient Safety Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. The First Treatment Specifically Approved for Huntingtons Disease Patients is Now Available in the United States
2. Life-Saving Airman, Leukemia Patient Meet for First Time
3. New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
4. Final Rule Issued for Patient Safety Organizations
5. Heart patients are often not treated in accordance with guidelines
6. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
7. Initial Survey Findings on Diabetes Awareness Released by PatientAssistance.com
8. When the Caregiver Becomes the Patient
9. Caution Urged as Patients Seek Deals on Cosmetic Surgery
10. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card
11. New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Preventing lung scarring may extend lives of lung cancer patients 2Health News:Rhode Island Hospital lands $11.1M grant from National Institutes of Health 2Health News:Rhode Island Hospital lands $11.1M grant from National Institutes of Health 3Health News:Rhode Island Hospital lands $11.1M grant from National Institutes of Health 4Health News:Rhode Island Hospital lands $11.1M grant from National Institutes of Health 5Health News:Kellogg School of Management Announces 'Code Red' 2Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 2Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 3Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 4Health News:The Organic Trade Association Hails Preliminary Research Findings Showing Nutritional Benefits of Organic Products 2Health News:HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index and the HealthShares(TM) Composite Index 2Health News:HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index and the HealthShares(TM) Composite Index 3
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 656 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 156 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 256 Year Old Grandmother Announces Attempt to Become First Woman to Complete the 4 Deserts 28TM 29 in Under a Year 56088 3Pelosi and Reid Invite President Obama to Address Congress 56085 1Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2